Join the Zembrace SymTouch group to help and get support from people like you.
Zembrace SymTouch News
No Increase Seen in Neurodevelopmental Disorders With Prenatal Triptan Use
WEDNESDAY, May 21, 2025 – Children prenatally exposed to different triptan intensities and duration, alone or in combination with other preventive medications for migraine, do not have increased...
Combination Therapy Recommended For Migraines
THURSDAY, March 20, 2025 – Doctors should prescribe triptans for migraine patients who aren’t receiving relief from over-the-counter (OTC) pain relievers, according to a new clinical guideline from t...
FDA Approves Tosymra (sumatriptan) Nasal Spray for Acute Treatment of Migraine
January 27, 2019 – Dr. Reddy’s Laboratories Ltd. and its subsidiary, Promius Pharma, LLC today announced the approval of Tosymra (previously known as DFN-02) by the U.S. Food and Drug Administration ...
Dr. Reddy’s Laboratories Ltd. Receives FDA Approval for Zembrace SymTouch (sumatriptan succinate) Injection for the Acute Treatment of Migraines
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that the U.S. Food and Drug Administration (FDA) has approved...